Showing results (101-110 of 264) with videos related to

Sort By:
Pageof 27
Journal of the American Academy of Dermatology|June 21, 2005
Decision points for the initiation of systemic treatment for psoriasisSteven R Feldman, John Y M Koo, Alan Menter, et al.
Clinical & Translational Immunology|September 5, 2017
Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infectionsMichael Kammüller, Tsen-Fang Tsai, Christopher Em Griffiths, et al.
Journal of the American Academy of Dermatology|January 16, 2013
Cutaneous manifestations of gastrointestinal disease: part IIBreck Thrash, Mahir Patel, Kejal R Shah, et al.
Expert Opinion on Pharmacotherapy|March 23, 2018
Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areasDario Kivelevitch, Jillian Frieder, Ian Watson, et al.
Seminars in Cutaneous Medicine and Surgery|April 4, 2018
The Evolving Landscape of Psoriasis TreatmentApril W Armstrong, Kenneth B Gordon, M Alan Menter, et al.
Seminars in Cutaneous Medicine and Surgery|April 4, 2018
Common and Not-So-Common Comorbidities of PsoriasisM Alan Menter, April W Armstrong, Kenneth B Gordon, et al.
Seminars in Cutaneous Medicine and Surgery|April 4, 2018
Practical Strategies for Optimizing Management of PsoriasisJashin J Wu, April W Armstrong, Kenneth B Gordon, et al.
Journal of the American Academy of Dermatology|January 16, 2013
Cutaneous manifestations of gastrointestinal disease: part IKejal R Shah, C Richard Boland, Mahir Patel, et al.
Journal of Drugs in Dermatology : JDD|May 10, 2014
Analysis of body regions and components of PASI scores during adalimumab or methotrexate treatment for patients with moderate-to-severe psoriasisAlexander A Navarini, Yves Poulin, Alan Menter, et al.
Pageof 27